Login / Signup

A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.

Jin-Shuai LanYan-Hong QinLi LiuRui-Feng ZengYang YangKai WangYue DingTong ZhangRodney J Y Ho
Published in: International journal of nanomedicine (2021)
Our findings indicate that the UA-MTX NPs targeting folate-receptors is an efficient strategy for combination chemotherapy.
Keyphrases
  • cancer therapy
  • high dose
  • locally advanced
  • drug delivery
  • stem cells
  • squamous cell carcinoma
  • low dose
  • binding protein
  • chemotherapy induced
  • replacement therapy
  • smoking cessation